Nanomedicine News RSS Feed - Nanomedicine

LD Micro Invitational: Matinas BioPharma to Present on Targeted Therapeutics

LD Micro Invitational: Matinas BioPharma to Present on Targeted Therapeutics

Matinas BioPharma Holdings, Inc. ("Matinas BioPharma" or the "Company"), a clinical-stage biopharmaceutical company principally focused on the development of targeted therapeutics for the treatment of infectious diseases, today announced that it will be presenting at the LD Micro Invitational being held June 1-3, 2015, at the Luxe Sunset Boulevard, Los Angeles, CA. [More]
Malvern's Nanoparticle Tracking Analysis Used in Development of Targeted microRNA Cancer Therapy at Ohio State University

Malvern's Nanoparticle Tracking Analysis Used in Development of Targeted microRNA Cancer Therapy at Ohio State University

Researchers in the Department of Chemical and Biomolecular Engineering at The Ohio State University (Columbus, Ohio, USA) are using Malvern Instruments’ NanoSight Nanoparticle Tracking Analysis (NTA) to study extracellular vesicle yields from different cell culture lines. [More]
Drug-Releasing, Multi-Tasking Electronic Stent Could Help Minimize Risks

Drug-Releasing, Multi-Tasking Electronic Stent Could Help Minimize Risks

Every year, an estimated half-million Americans undergo surgery to have a stent prop open a coronary artery narrowed by plaque. But sometimes the mesh tubes get clogged. Scientists report in the journal ACS Nano a new kind of multi-tasking stent that could minimize the risks associated with the procedure. It can sense blood flow and temperature, store and transmit the information for analysis and can be absorbed by the body after it finishes its job. [More]
Revolutionary Nanotechnology Could Help Prevent Deep Bone Infections

Revolutionary Nanotechnology Could Help Prevent Deep Bone Infections

Leading scientists at the University of Sheffield have discovered nanotechnology could hold the key to preventing deep bone infections, after developing a treatment which prevents bacteria and other harmful microorganisms growing. [More]
Eighteen Studies Utilizing Nanosphere Verigene Multiplex Infectious Disease Tests Presented at CVS, ECCMID, and MAD-ID

Eighteen Studies Utilizing Nanosphere Verigene Multiplex Infectious Disease Tests Presented at CVS, ECCMID, and MAD-ID

Nanosphere, Inc., a company enhancing medicine through targeted molecular diagnostics, today announced that 18 studies performed by various U.S. and international hospitals were recently presented at the annual Clinical Virology Symposium (CVS) in Daytona Beach, Florida, the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) in Copenhagen, Denmark, and the Making a Difference in Infectious Diseases (MAD-ID) Conference in Orlando, Florida. [More]
Small, Simple Chip Can Test for Antibiotic Resistance Within One Hour

Small, Simple Chip Can Test for Antibiotic Resistance Within One Hour

We live in fear of 'superbugs': infectious bacteria that don't respond to treatment by antibiotics, and can turn a routine hospital stay into a nightmare. A 2015 Health Canada report estimates that superbugs have already cost Canadians $1 billion, and are a "serious and growing issue." Each year two million people in the U.S. contract antibiotic-resistant infections, and at least 23,000 people die as a direct result. [More]
FDA Grants Orphan Drug Designation to Cerulean’s CRLX101 Nanoparticle-Drug Conjugate

FDA Grants Orphan Drug Designation to Cerulean’s CRLX101 Nanoparticle-Drug Conjugate

Cerulean Pharma Inc. today announced that the U.S. Food and Drug Administration, or FDA, has granted orphan drug designation to CRLX101 for the treatment of ovarian cancer. [More]
Matinas BioPharma to Present Amphotericin B Nano-Particle Formulation at SeeThru Equity Microcap Investor Conference

Matinas BioPharma to Present Amphotericin B Nano-Particle Formulation at SeeThru Equity Microcap Investor Conference

Matinas BioPharma Holdings, Inc. ("Matinas BioPharma" or the "Company"), a clinical-stage biopharmaceutical company principally focused on the development of lipid-based prescription therapeutics for the treatment of infectious diseases, today announced that it will be presenting at the Fourth Annual SeeThru Equity Microcap Investor Conference being held May 28, 2015, at Convene Grand Central, New York, NY. [More]
Cedars-Sinai Nano Delivery System Identifies and Attacks Cancers

Cedars-Sinai Nano Delivery System Identifies and Attacks Cancers

Biomedical researchers at Cedars-Sinai have invented a tiny drug-delivery system that can identify cancer cell types in the brain through “virtual biopsies” and then attack the molecular structure of the disease. [More]
Multiplexing Technique Enables Faster Completion of NanoMRI Scans

Multiplexing Technique Enables Faster Completion of NanoMRI Scans

NanoMRI is a scanning technique that produces nondestructive, high-resolution 3-D images of nanoscale objects, and it promises to become a powerful tool for researchers and companies exploring the shape and function of biological materials such as viruses and cells in much the same way as clinical MRI today enables investigation of whole tissues in the human body. [More]
Site Sponsors
  • Oxford Instruments Nanoanalysis - X-Max Large Area Analytical EDS SDD
  • Strem Chemicals - Nanomaterials for R&D
  • Park Systems - Manufacturer of a complete range of AFM solutions